Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2008;25(12):989-92.
doi: 10.1002/da.20540.

Treatment-resistant depression: recent developments and future directions

Sanjay J Mathew  1
Affiliations
Review

Treatment-resistant depression: recent developments and future directions

Sanjay J Mathew. Depress Anxiety. 2008.
No abstract available

PubMed Disclaimer

References

    1. Rush AJ, Thase ME, Dube S. Research issues in the study of difficult-to-treat depression. Biol Psychiatry. 2003;53:743–753. - PubMed
    1. European Agency for the Evaluation of Medicinal Products Evaluation of Medicines for Human Use. Note for Guidance on Clinical Investigation of Medicinal Products in the Treatment of Depression. London, England. //www.emea.europa.eu/pdfs/human/ewp/051897en.pdf.
    1. Souery D, Oswald P, Massat I, et al. Clinical factors associated with treatment resistance in major depressive disorder: results from a European multicenter study. J Clin Psychiatry. 2007;68:1062–1070. - PubMed
    1. Rush AJ, Trivedi MH, Wisniewski SR, et al. Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression. N Engl J Med. 2006;354(12):1231–1242. - PubMed
    1. Trivedi MH, Rush AJ, Gaynes BN, et al. Maximizing the adequacy of medication treatment in controlled trials and clinical practice: STAR*D measurement-based care. Neuropsychopharmacology. 2007;32:2479–2489. - PubMed

Publication types

MeSH terms